# Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

> **NCT02739698** · PHASE2 · COMPLETED · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 32 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Paclitaxel
- **PROCEDURE:** Radical surgery-peritonectomy

## Key facts

- **NCT ID:** NCT02739698
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-11
- **Final completion:** 2017-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739698, "Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02739698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*